Overview


According to FutureWise analysis the market for Traumatic Brain Injuries Treatment in 2023 is US$ 1.85 billion, and is expected to reach US$ 3.61 billion by 2031 at a CAGR of 8.70%.

Globally, traumatic brain injuries (TBI) account for a substantial number of cases each year. A traumatic brain injury results from externally inflicted trauma causing damage to the brain cells and blood vessels. Signs and symptoms of TBI may appear soon after the head trauma or may take several days to weeks. When a mild injury occurs, a patient may experience a brief concussion and in rare cases, functional brain changes may persist. The risk of developing severe and permanent brain damage increases with the severity and extent of the traumatic brain injury and the level of unconsciousness. A moderate to severe brain injury can cause dementia along with memory loss, loss of concentration, problems with speech, eating, lack of coordination, and walking problems. The treatment of mild traumatic brain injuries is limited to over-the-counter pain relievers, and patients with mild traumatic brain injuries do not have to be hospitalized. To treat severe TBI, several medications are indicated, including several diuretics, anti-seizure drugs, and comma inducing drugs. Surgery and rehabilitation are needed, however, in cases of severe TBI.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Traumatic Brain Injuries Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Traumatic Brain Injuries Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Zimmer Biomet
  • Neuren Pharmaceuticals Ltd.
  • Oxygen Biotherapeutics Inc.
  • TEVA Pharmaceutical Industries Ltd.
  • Ischemic
  • Stemedica Cell Technologies Inc
  • AMARANTUS BIOSCIENCE HOLDINGS INC
  • Grace Laboratories LLC.
  • Medicortex Finland Oy
  • Medtronic Plc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Treatment Type

  • Drugs
    • Drug Class
      • Analgesics
      • Anti-Anxiety Agents
      • Anti-Coagulants
      • Anti-Convulsants
      • Anti-Depressants
      • Anti-Psychotics
      • Other Drug Classes
    • Route of Administration
      • Oral
      • Injectable
    • Distribution Channel
      • Hospital Pharmacies
      • Drug Stores
      • Independent Pharmacies
  • Surgery Type
    • Craniotomy with Open Surgery
    • Endoscopic Ventriculostomy
    • Ventriculoperitoneal Shunt Surgery
    • Decompressive Craniectomy
    • Cranioplasty
    • Others

By Indication

  • Hydrocephalus
  • Skull Fractures
  • Intracerebral Hemorrhages
  • Hematomas
  • Other Indications

By End-User

  • Hospitals
  • Neurology Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Traumatic Brain Injuries Treatment Market By Treatment Type, By Indication, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Traumatic Brain Injuries Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Traumatic Brain Injuries Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Traumatic Brain Injuries Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Traumatic Brain Injuries Treatment Market, By Treatment Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Drugs
         1.1. Drug Class
          1.1.1. Analgesics
          1.1.2. Anti-Anxiety Agents
          1.1.3. Anti-Coagulants
          1.1.4. Anti-Convulsants
          1.1.5. Anti-Depressants
          1.1.6. Anti-Psychotics
          1.1.7. Other Drug Classes
         1.2. Route of Administration
          1.2.1. Oral
          1.2.2. Injectable
         1.3. Distribution Channel
          1.3.1. Hospital Pharmacies
          1.3.2. Drug Stores
          1.3.3. Independent Pharmacies
        2. Surgery Type
         2.1. Craniotomy with Open Surgery
         2.2. Endoscopic Ventriculostomy
         2.3. Ventriculoperitoneal Shunt Surgery
         2.4. Decompressive Craniectomy
         2.5. Cranioplasty
         2.6. Others

  • 8.   Traumatic Brain Injuries Treatment Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hydrocephalus
        2. Skull Fractures
        3. Intracerebral Hemorrhages
        4. Hematomas
        5. Other Indications

  • 9.   Traumatic Brain Injuries Treatment Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Neurology Clinics
        3. Ambulatory Surgical Centers

  • 10.   North America Traumatic Brain Injuries Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Traumatic Brain Injuries Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Traumatic Brain Injuries Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Traumatic Brain Injuries Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Traumatic Brain Injuries Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Zimmer Biomet
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Neuren Pharmaceuticals Ltd.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Oxygen Biotherapeutics Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. TEVA Pharmaceutical Industries Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Ischemic
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Stemedica Cell Technologies Inc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. AMARANTUS BIOSCIENCE HOLDINGS INC
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Grace Laboratories LLC.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Medicortex Finland Oy
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Medtronic Plc
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients